Explore Stanford technologies available for licensing:

Stanford researchers have developed an innovative brain-machine interface aimed at restoring communication for individuals with paralysis by translating their attempted speech into text.

Stanford researchers have developed a novel approach to selectively regulate and monitor immune responses in specific mucosal tissues, using the GPCR receptor GPR25 and its ligand CXCL17, which targets lymphocyte localization to non-intestinal mucosal tissues, enabling selecti

Stanford scientists have developed a high throughput screening method to identify therapeutics known as translational activators to treat protein synthesis disorders and ribosomopathies.

Stanford researchers have developed a method using trained learning models to optimize synthetic DNA libraries for high-throughput molecular biology experiments.

Stanford researchers have developed a vision-language foundation model designed to leverage large-scale, unlabeled, unpaired image and text data.

Stanford inventors have developed a method to efficiently differentiate human pluripotent stem cells (hPSCs) into nearly pure populations of human blood progenitors or blood vessel cells in a Petri dish.

Stanford researchers in Prof. Corinne Beinat's lab have developed a small molecule radiotheranostic for targeted radionuclide therapy of cancers overexpressing system xc-, such as high-grade glioma and non-small cell lung cancer (NSCLC).

Stanford researchers in Prof. Engleman and Reticker-Flynn's labs have created a novel cell therapy that targets the T-antigen, a prominent tumor-specific antigen, by leveraging the high avidity interactions between lectins and glycans.

Undulator magnet cores are essential for advanced applications such as synchrotron radiation sources, advanced chip manufacturing, and fusion technology. SLAC researchers have a new manufacturing approach that achieves greater precision at significantly lower costs.

Stanford researchers have developed ModulADAR - a novel RNA sensing platform that enables precise, cell-type or state-specific activation of mRNA expression using ADAR editing, offering unparalleled flexibility and specificity for targeted RNA therapeutics.

Hydrogen that is free of greenhouse gas (GHG) emissions is a key vector to fuel a net-zero emissions economy, but today's H2 is sourced from fossil fuels mostly by the highly emissions-intensive processes of steam methane reforming (SMR) or coal gasification.

Stanford University and University of Wisconsin–Madison researchers have developed a new device to achieve upconversion (UC) of incoherent near-infrared (NIR) photons beyond 1100nm to visible photons, through sensitized triplet–triplet annihilation (TTA).

Stanford researchers have identified a novel approach to directly inhibit the receptor tyrosine kinase AXL (also known as UFO, ARK, and Tyro7) from interacting with its ligand, GAS6.

Researchers in Prof. Amato Giaccia's laboratory have discovered that preventing Axl signaling can reduce tumor-related fibrosis. Axl is a receptor tyrosine kinase that is activated by its ligand, Gas6.

Stanford researchers have developed a pioneering autonomous radiation-therapy treatment planning tool for clinical implementation.